Clinical Trial Update: Lithium for Parkinson's: an Extension Trial [Phase 1, Phase 2]

View source ↗

Summary

An extension trial evaluating lithium in Parkinson's disease is currently enrolling by invitation in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Lithium (Lithium carbonate)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION